We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis.
- Authors
Pineda, J A; Santos, J; Rivero, A; Abdel-Kader, L; Palacios, R; Camacho, A; Lozano, F; Macías, J; Liverey Study Investigator Team
- Abstract
To appraise the rate of grade 3-4 transaminase elevations (TEs) and grade 4 total bilirubin elevation (TBE) in patients co-infected with human immunodeficiency virus (HIV) and hepatitis C or hepatitis B virus (HCV or HBV, respectively) who receive atazanavir/ritonavir. Moreover, the relationship between these events and the degree of prior liver fibrosis was evaluated.
- Publication
The Journal of antimicrobial chemotherapy, 2008, Vol 61, Issue 4, p925
- ISSN
1460-2091
- Publication type
Journal Article
- DOI
10.1093/jac/dkn045